Intelligent Bio Solutions Inc. Expands Global Presence with SMARTOX Distribution Agreement
TL;DR
Intelligent Bio Solutions expands its market reach with SMARTOX, offering a competitive edge in the global drug testing market projected to hit $18.6 billion by 2030.
Intelligent Bio Solutions partners with SMARTOX to distribute the SmarTest Patch, a sweat-based drug detection product, enhancing its non-invasive testing portfolio internationally.
The global distribution of the SmarTest Patch by Intelligent Bio Solutions and SMARTOX aims to improve workplace safety and public health through innovative drug detection.
Discover how Intelligent Bio Solutions is transforming drug testing with fingerprint and sweat-based technologies, making detection faster and non-invasive.
Found this article helpful?
Share it with your network and spread the knowledge!
Intelligent Bio Solutions Inc. (NASDAQ: INBS), a leader in non-invasive medical testing technologies, has announced a significant expansion of its global footprint through a distribution agreement with SMARTOX(R). This partnership will introduce the SmarTest Patch, a sweat-based drug detection product, to markets outside the U.S. and Canada, marking a pivotal step in INBS's international growth strategy.
The SmarTest Patch offers continuous drug monitoring, complementing INBS's existing fingerprint-based testing solutions already distributed by SMARTOX in the U.S. forensic sector. This collaboration not only broadens INBS's product offerings but also taps into the burgeoning global drug testing market, projected to reach $18.6 billion by 2030. The agreement signifies a new revenue stream for INBS, aligning with its mission to provide innovative, rapid, and non-invasive testing solutions worldwide.
INBS's Intelligent Fingerprinting Drug Screening System, known for its efficiency and hygiene, screens for recent use of drugs such as opiates, cocaine, methamphetamine, and cannabis. With results available in under ten minutes, this technology is particularly valuable for employers in safety-critical industries. The expansion into international markets through the SMARTOX deal underscores INBS's commitment to addressing global demand for advanced drug testing solutions.
For more details on this development, visit https://ibn.fm/X6YbK.
Curated from InvestorBrandNetwork (IBN)
